COVID-19
FDA, CDC consider authorizing COVID vaccine for kids age 5-11
October 25, 2021
UT Health San Antonio medical and scientific experts are preparing a public education campaign about the importance of getting COVID-19 vaccinations now to prevent the possibility of a winter surge. The organization also is preparing to provide COVID-19 vaccinations for children ages 5-11 when the vaccine receives emergency use authorization, which is expected in early November.
Immunologic resilience: A new metric to accurately gauge COVID-19’s path
September 9, 2021
Researchers from The University of Texas Health Science Center at San Antonio and the South Texas Veterans Health Care System unveiled a novel concept, “immunologic resilience,” to accurately predict which COVID-19 patients will advance to severe disease and which will not.
COVID-19 vaccine third dose: Who is eligible and how to get one
August 16, 2021
Currently, the CDC is recommending the third dose for only moderately to severely immunocompromised persons.
Delta variant facts from UT Health San Antonio experts
August 10, 2021
As children return to area schools this month, here are some points of interest about the delta COVID variant from experts at UT Health San Antonio.
Thinking impaired in COVID-19 survivors, study finds
August 2, 2021
In a sample of more than 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment.
Can a vitamin treat COVID-19-related acute kidney injury?
July 27, 2021
Researchers at UT Health San Antonio, The University of Washington at Seattle and the Icahn School of Medicine at Mount Sinai in New York have launched NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury (AKI) in COVID-19 patients.